Paper · 39200293
Exploring the Role of Hormones and Cytokines in Osteoporosis Development.
Umur E and 8 others. Biomedicines, 2024. Cited by 41 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Exploring the Role of Hormones and Cytokines in Osteoporosis Development. Papers, record 39200293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39200293
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References365
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9,783,546 | Effects of estrogen therapy of postmenopausal women on cytokines measured in peripheral blood. | J Bone Miner Res | 1998 | https://conductscience.org/library/papers/9783546 | PubMed |
| 2 | 10,936,147 | Proinflammatory cytokines. | Chest | 2000 | https://conductscience.org/library/papers/10936147 | PubMed |
| 3 | 19,539,794 | Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin. | Bone | 2009 | https://conductscience.org/library/papers/19539794 | PubMed |
| 4 | 10,358,772 | The IL-4 receptor: signaling mechanisms and biologic functions. | Annu Rev Immunol | 1999 | https://conductscience.org/library/papers/10358772 | PubMed |
| 5 | 29,942,929 | Fibroblast Growth Factor 2 and Its Receptors in Bone Biology and Disease. | J Endocr Soc | 2018 | https://conductscience.org/library/papers/29942929 | PubMed |
| 6 | 9,389,739 | Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha. | J Clin Invest | 1997 | https://conductscience.org/library/papers/9389739 | PubMed |
| 7 | 22,161,825 | The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology. | Int J Dev Biol | 2011 | https://conductscience.org/library/papers/22161825 | PubMed |
| 8 | 18,450,470 | The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33. | Cytokine | 2008 | https://conductscience.org/library/papers/18450470 | PubMed |
| 9 | 1,831,327 | Human osteoblasts synthesize and respond to platelet-derived growth factor. | Am J Physiol | 1991 | https://conductscience.org/library/papers/1831327 | PubMed |
| 10 | 31,404,890 | Interleukin-35 stimulates tumor necrosis factor-α activated osteoblasts differentiation through Wnt/β-catenin signaling pathway in rheumatoid arthritis. | Int Immunopharmacol | 2019 | https://conductscience.org/library/papers/31404890 | PubMed |
1 to 10 of 365
See all 365 referencesCited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,761,519 | Targeting subchondral osteoporosis in osteoarthritis: biomechanical crosstalk and the therapeutic rationale for inflammatory microenvironment remodeling. | Front Immunol | 2026 | https://conductscience.org/library/papers/42761519 | PubMed |
| 42,666,577 | Retrospective Development and Internal Validation of a Diagnostic Model to Identify Secondary Osteoporosis in Community-Dwelling Older Men. | Orthop Res Rev | 2026 | https://conductscience.org/library/papers/42666577 | PubMed |
| 42,312,209 | Stress-induced IL-6 regulation in pediatric bone growth disorders: current insights and therapeutic strategies. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42312209 | PubMed |
| 42,199,525 | Cellular signaling crosstalk between osteoporosis and diabetes: Common mechanisms and therapeutic targets (Review). | Biomed Rep | 2026 | https://conductscience.org/library/papers/42199525 | PubMed |
| 41,987,774 | Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and osteoporotic fracture. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/41987774 | PubMed |
| 41,976,789 | Glucocorticoid-Induced Osteoporosis: Pathogenesis, the Impact of Different Administration Routes on Bone Mineral Density, and Fracture Risk and Treatment Options-A Narrative Review. | J Clin Med | 2026 | https://conductscience.org/library/papers/41976789 | PubMed |
| 41,852,468 | The role and mechanisms of bone microenvironment regulators in osteoporosis: novel intervention strategies for addressing the challenges of aging. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/41852468 | PubMed |
| 41,833,304 | Ergothioneine prevents ovariectomy-induced osteoporosis by suppressing NF-κB/p65 signalling to attenuate osteoclastogenesis and bone marrow inflammation. | Bone Joint Res | 2026 | https://conductscience.org/library/papers/41833304 | PubMed |
| 41,827,986 | Osteoimmunologic and Immune-Aging Signatures in Postmenopausal Women with Periodontitis and Low Bone Mineral Density: A Cross-Sectional Study. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/41827986 | PubMed |
| 41,810,100 | HUC-MSC secretome and Nanoemulsion Propolis synergistically modulate inflammatory responses in hyperglycemia-induced calvarial osteolysis. | J Oral Biol Craniofac Res | 2026 | https://conductscience.org/library/papers/41810100 | PubMed |
1 to 10 of 33
See all 33 cited byGenes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| TNFRSF11B | 4,982 | PubTator's text mining | https://conductscience.org/library/genes/4982 | NCBI Gene |
| TNFSF11 | 8,600 | PubTator's text mining | https://conductscience.org/library/genes/8600 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39200293
GET https://conductscience.org/api/papers/v1/39200293/references?page=2